Earnings
-
Protected: VIDEO: Danimer Scientific debuts on NY Stock Exchange
.
There is no excerpt because this is a protected post.
-
Biofuel, Bioplastic, butanol, Clean technology, Company initiatives, Earnings, Investments, Press Release, R&DDowDuPont plans to sell its Biomaterials business
.
When former DuPont CEO Ellen Kullman was at the helm, DuPont had been keen on building its industrial biosciences business unit as a global powerhouse as it shifted its strategy in expanding this business with the acquisition of Danisco for $7 billion back in 2011. Enzymes, bioactive solutions, biomaterials, and biorefining products were the key…
-
BioAmber files for Bankruptcy
.
Unfortunately, the force is not that strong for BioAmber today as the company announced its filing for Chapter 11 Bankruptcy in the US, while its two Canadian subsidiaries – BioAmber Sarnia Inc. and BioAmber Canada Inc. also filed a notice of bankruptcy intention as well in Canada. The company said these procedures are the best…
-
Hard times for public renewable chemical companies
.
The past year and a half (or almost two years) has been very hard for public chemical companies as Codexis and Solazyme (now Terravia) reinvented themselves, while Gevo and Metabolix shareholders seem to be now looking into selling the companies as options due to financial difficulties. Gevo just announced that it hired Cowen & Company to explore…
-
BioAmber Reports Earnings Results
.
It is 2am in the morning and when I can’t sleep, that means it is time to blog. BioAmber released its 4Q and Full Year 2014 financial results yesterday reporting construction progress and on budget for its 30 ktpa bio-succinic acid plant in Sarnia, Ontario, Canada, with a goal to be in commercial operation by…
-
Solazyme still faces production challenges at Moema
.
I wonder how long the petrochemical industry had perfected its processing technologies before it was able to reach an economical, efficient level? Unfortunately, investors today are not too forgiving when new, untested technologies from public companies are facing commercialization challenges. Solazyme is now going through this stage and their stocks had plunged from $11.79 a…
-
Turnaround for Amyris
.
Despite the current water shortage (due to drought) and electricity problems in Brazil, Amyris seems to be doing well according to the company’s third quarter earnings report. Amyris said its Brotas biorefinery plant in Brazil has been running for 3 months without any unscheduled interruptions. The company expects to continue operations until the sugarcane season…